These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16221693)

  • 1. Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus.
    Ersoy A; Ersoy C; Altinay T
    Nephrol Dial Transplant; 2006 Feb; 21(2):553-4. PubMed ID: 16221693
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes: the role of basal insulin therapy.
    LeRoith D; Levetan CS; Hirsch IB; Riddle MC
    J Fam Pract; 2004 Mar; 53(3):215-22. PubMed ID: 15000929
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin therapy in renal disease.
    Iglesias P; Díez JJ
    Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of sudden death in dialysis patients.
    Ritz E; Wanner C
    Clin J Am Soc Nephrol; 2008 May; 3(3):920-9. PubMed ID: 18372318
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with Glurenorm in type 2 diabetics with renal insufficiency].
    Rybka J; Gregorová A; Zmydlená A
    Vnitr Lek; 1988 Aug; 34(8):786-92. PubMed ID: 3176368
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment: insulin strategies for type 2 diabetes mellitus.
    Davidson JA
    Ann Pharmacother; 2005 May; 39(5):975-6; author reply 976. PubMed ID: 15811902
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin].
    Hasslacher C; Vogt C; Raupp D; Dreyhaupt J
    Dtsch Med Wochenschr; 2007 Nov; 132(47):2500-4. PubMed ID: 18027324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-acting insulin analogues vs. human insulin for diabetes.
    Schooff M; Ehlers K
    Am Fam Physician; 2005 Sep; 72(5):805-7. PubMed ID: 16156336
    [No Abstract]   [Full Text] [Related]  

  • 10. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Question: is insulin glargine more effective?
    Kitowicz A; Criswell DF
    J Okla State Med Assoc; 2007 Jan; 100(1):26-7. PubMed ID: 17378499
    [No Abstract]   [Full Text] [Related]  

  • 12. [Better metabolic control with patient-focused insulin administration].
    Med Monatsschr Pharm; 2005 Oct; 28(10):366. PubMed ID: 16245457
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin therapy in type 2 diabetes: short-acting insulin analog has advantages].
    MMW Fortschr Med; 2006 Jun; 148(26):56-7. PubMed ID: 16875384
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of oral antidiabetic agents in primary care.
    Weekes AJ; Thomas MC
    Aust Fam Physician; 2007 Jun; 36(6):477-80. PubMed ID: 17565410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Type 2 diabetes: new insulins and new therapeutic strategies].
    Sauvanet JP
    Diabetes Metab; 2004 Nov; 30(5):478-80. PubMed ID: 15682547
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional therapy with insulin.
    Nattrass M
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):13-6. PubMed ID: 19667600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining effective insulin analog therapy based on the individualized needs of patients with type 2 diabetes mellitus.
    Gong WC
    Pharmacotherapy; 2008 Oct; 28(10):1299-308. PubMed ID: 18823224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating insulin in type 2 diabetes mellitus: the earlier the better.
    Cohen O
    Isr Med Assoc J; 2004 May; 6(5):292-4. PubMed ID: 15151371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.